10 Apr 2017
(MENAFN) Egypt should enhance its collaboration in pharmaceutical sector with India, which has great advantages in terms of offering affordable and reliable medication.
Accordingly, Egypt is a huge market in which India sees growing export potentials as well as possibilities of investments, while it aims that the market will offer India the base to increase to other parts of the region.
Additionally, India formulation is backed by globally acceptable certification and updated by increasing R&D facilities.
India’s exports of pharmaceuticals in 2015/16 reached USD16.86bn, while Indian pharmaceutical industry with several thousand producers, export the largest share of generics to the world.
MENAFN1004201700450000ID1095382304
MENAFN1004201700450000ID1095382304
17 Nov 2024
BBK and Asia Jewellers announce exclusive offers to its customers at Jewellery Arabia 2024
12 Nov 2024
BBK partners with Durrat Al Bahrain to offer exclusive financing for Jawhart Al Marjan
05 Nov 2024
As part of its digital transformation journey, BBK adds Google Wallet to its range of digital wallets
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more